Efficient synthesis of valsartan, a nonpeptide angiotensin II receptor antagonist

被引:17
作者
Zhang, C
Zheng, GJ
Fang, LJ
Li, YL [1 ]
机构
[1] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Inst Organ Chem, Lanzhou 730000, Peoples R China
[3] Zhejiang Hisun Pharmaceut Co Ltd, Taizhou 318000, Peoples R China
关键词
valsartan; antihypertensive therapy; directed orthometalation; palladium-catalyzed Suzuki coupling; methyl ester saponification;
D O I
10.1055/s-2006-926234
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A highly efficient and convergent approach to the synthesis of the angiotensin II receptor antagonist valsartan (1), one of the most important agents used in anti h yperten sive therapy today, is described. Directed ortho-metalation of 4-bromotoluene provides the key boronic acid intermediate II which was subjected to palladium-catalyzed Suzuki coupling. This method overcomes many of the drawbacks associated with the previously reported syntheses. The saponification of the methyl ester in valsartan was realized in a convenient and economical manner, which is more suitable for industrial production.
引用
收藏
页码:475 / 477
页数:3
相关论文
共 22 条
[1]   SEQUENTIAL DIRECTED ORTHO METALATION BORONIC ACID CROSS-COUPLING REACTIONS - A GENERAL REGIOSPECIFIC ROUTE TO OXYGENATED DIBENZO[B,D]PYRAN-6-ONES RELATED TO ELLAGIC ACID [J].
ALO, BI ;
KANDIL, A ;
PATIL, PA ;
SHARP, MJ ;
SIDDIQUI, MA ;
SNIECKUS, V ;
JOSEPHY, PD .
JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (12) :3763-3768
[2]   VALSARTAN, A POTENT, ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONIST DEVELOPED FROM THE STRUCTURALLY NEW AMINO-ACID SERIES [J].
BUHLMAYER, P ;
FURET, P ;
CRISCIONE, L ;
DEGASPARO, M ;
WHITEBREAD, S ;
SCHMIDLIN, T ;
LATTMANN, R ;
WOOD, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) :29-34
[3]  
BUHLMAYER P, 1991, Patent No. 4439883
[4]  
Buhlmayer P., 1995, U.S. Patent, Patent No. 5339578
[5]   NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE DISCOVERY OF A SERIES OF N-(BIPHENYLYLMETHYL)IMIDAZOLES AS POTENT, ORALLY ACTIVE ANTIHYPERTENSIVES [J].
CARINI, DJ ;
DUNCIA, JV ;
ALDRICH, PE ;
CHIU, AT ;
JOHNSON, AL ;
PIERCE, ME ;
PRICE, WA ;
SANTELLA, JB ;
WELLS, GJ ;
WEXLER, RR ;
WONG, PC ;
YOO, SE ;
TIMMERMANS, PBMWM .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2525-2547
[6]  
CEPANEC I, 2005, Patent No. 04958
[7]   PHARMACOLOGICAL PROFILE OF VALSARTAN - A POTENT, ORALLY-ACTIVE, NONPEPTIDE ANTAGONIST OF THE ANGIOTENSIN-II AT1-RECEPTOR SUBTYPE [J].
CRISCIONE, L ;
DEGASPARO, M ;
BUHLMAYER, P ;
WHITEBREAD, S ;
RAMJOUE, HPR ;
WOOD, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) :761-771
[8]   THE DISCOVERY OF POTENT NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - A NEW CLASS OF POTENT ANTIHYPERTENSIVES [J].
DUNCIA, JV ;
CHIU, AT ;
CARINI, DJ ;
GREGORY, GB ;
JOHNSON, AL ;
PRICE, WA ;
WELLS, GJ ;
WONG, PC ;
CALABRESE, JC ;
TIMMERMANS, PBMWM .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (05) :1312-1329
[9]  
KALININ VN, 1992, SYNTHESIS-STUTTGART, P431
[10]  
MANTLO NB, 1991, J MED CHEM, V34, P2922